These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9375876)

  • 1. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections.
    Euler HH; Harten P; Zeuner RA; Schwab UM
    J Rheumatol; 1997 Nov; 24(11):2153-7. PubMed ID: 9375876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [G-CSF in patients with lupus-associated neutropenia and infections].
    Schwab UM; Harten P; Zeuner RA; Külper M; Euler HH
    Z Rheumatol; 1996; 55(3):174-9. PubMed ID: 8768147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor.
    Krishnaswamy G; Odem C; Chi DS; Kalbfleisch J; Baker N; Smith JK
    J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis.
    Hellmich B; Schnabel A; Gross WL
    Arthritis Rheum; 1999 Aug; 42(8):1752-6. PubMed ID: 10446877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares.
    Vasiliu IM; Petri MA; Baer AN
    J Rheumatol; 2006 Sep; 33(9):1878-80. PubMed ID: 16832843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
    Beaupain B; Leblanc T; Reman O; Hermine O; Vannier JP; Suarez F; Lutz P; Bordigoni P; Jourdain A; Schoenvald M; Ouachee M; François S; Kohser F; Jardin F; Devouassoux G; Bertrand Y; Nove-Josserand R; Donadieu J;
    Pediatr Blood Cancer; 2009 Dec; 53(6):1068-73. PubMed ID: 19618456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)].
    Schwander S; Kern P
    Med Klin (Munich); 1993 Feb; 88(2):60-2. PubMed ID: 7680750
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.
    Carulli G; Lazzeri E; Lagomarsini G; Zucca A; Cannizzo E; Riccioni R; Petrini M
    Clin Ter; 2007; 158(3):235-7. PubMed ID: 17612284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filgrastim for lupus neutropenia.
    Euler HH; Schwab UM; Schroeder JO
    Lancet; 1994 Nov; 344(8935):1513-4. PubMed ID: 7526104
    [No Abstract]   [Full Text] [Related]  

  • 19. Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer.
    Arnedos M; Sutherland S; Ashley S; Smith I
    Breast Cancer Res Treat; 2008 Nov; 112(1):1-4. PubMed ID: 18060493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic neutropenia and defect in superoxide generation of granulocytes in two patients: enhancement of bactericidal capacity and respiratory burst activity by treatment with recombinant human granulocyte colony-stimulating factor.
    Káposzta R; Maródi L
    Pediatr Res; 1995 Jan; 37(1):50-5. PubMed ID: 7535420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.